This application seeks to permit the voluntary use of 2′-FL, 3-FL, LNT, 3′-SL, and 6′-SL, alone or in combination, as nutritive substances in infant formula products. The nutritive substance ingredients are derived from various genetically modified Escherichia coli BL21 strains.
Administrative Assessment
